Unlearn.ai
AI-powered digital twins and scientific intelligence for faster, smarter clinical trials
Enterprise·Technical·Powered by Unlearn proprietary AI
Key strengths
AI-generated digital twins for patient outcome forecastingEMA-qualified methodology aligned with FDA guidanceIntegrated platform covering trial planning, monitoring, and analysisAutomated literature and regulatory precedent search (Scout)Measurable reductions in control arm size (~33%) and enrollment time (4+ months)
Enterprise pricing
US
Facts verified against unlearn.ai on
Get alerts when Unlearn.ai changes
Free. We'll email you when pricing, the free tier, API access or open-source status changes.
No ratings yet
Documentation & Integration
Unlearn is designed for pharmaceutical and biotech teams managing clinical trial operations and data science workflows. The platform supports:
- Randomized controlled trials (RCTs) and single-arm studies, covering the breadth of common clinical trial designs
- Application at multiple lifecycle stages: pre-trial design, mid-trial augmentation, and post-readout analysis
- Control arm augmentation workflows that reduce required control arm enrollment by approximately 33%
For detailed API references, integration guides, and methodology documentation, consult Unlearn's official developer and clinical documentation resources directly.
Alternatives
See all alternatives Alternatives to Unlearn.ai
Is Unlearn.ai yours? Claim the listing & get the badge